The Fund is a low volatility, low leverage, diversified, long/short hedge fund, investing across the full spectrum of the US healthcare market (healthcare services, pharmaceutical, biotech, and medical technology). CCI employs a bottom-up, fundamental approach. We look for companies experiencing a positive fundamental change in business momentum and for companies whose results are exceeding investors expectations. Maximum leverage is 150% gross long. To mitigate risk we use shorts, options, ETF's, and put limits on exposure to sub-sectors as well as a maximum of 5% at cost for all position sizes.